Inovio Pharmaceuticals (INO) Enterprise Value (2010 - 2026)
Inovio Pharmaceuticals (INO) reported Enterprise Value of $53.11 million for Q2 2026, up 67.7% from $31.66 million a year earlier but down 49.6% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Enterprise Value (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Inovio Pharmaceuticals' Enterprise Value came in at -$93.89 million; for FY2025, it came in at $23.07 million.
- Enterprise Value has a five-year compound annual growth rate of -52.6% (FY2020 to FY2025).
- By year, Enterprise Value came in at -$44.41 million in FY2024, -$5.8 million in FY2023, $141.81 million in FY2022 (-79.2%) and $683.38 million in FY2021 (-28.9%).
- Five-year quarterly Enterprise Value spans a low of -$74.3 million in Q2 2023 and a high of $1.11 billion in Q3 2021.
- The high point for year-over-year Enterprise Value in five years was Q2 2026 (growth of 67.7%); the low point was Q2 2022 (a decline of 94.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $105.47 million (Q1 2026), $23.07 million (Q4 2025) and $74.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Inovio Pharmaceuticals | 68.56 Mn | -115.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.11 Mn |
| Mar 31, 2026 | 105.47 Mn |
| Dec 31, 2025 | 23.07 Mn |
| Sep 30, 2025 | 74.55 Mn |
| Jun 30, 2025 | 31.66 Mn |
| Mar 31, 2025 | -8.58 Mn |
| Dec 31, 2024 | -44.41 Mn |
| Sep 30, 2024 | 66.05 Mn |
| Jun 30, 2024 | 99.37 Mn |
| Mar 31, 2024 | 254.03 Mn |
| Dec 31, 2023 | -5.80 Mn |
| Sep 30, 2023 | -61.01 Mn |
| Jun 30, 2023 | -74.30 Mn |
| Mar 31, 2023 | -8.31 Mn |
| Dec 31, 2022 | 141.81 Mn |
| Sep 30, 2022 | 149.72 Mn |
| Jun 30, 2022 | 83.32 Mn |
| Mar 31, 2022 | 461.83 Mn |
| Dec 31, 2021 | 683.38 Mn |
| Sep 30, 2021 | 1.11 Bn |
API Access
Inovio Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();